Intermittent Oral Tube in Alzheimer's Patients - Trial NCT06328829
Access comprehensive clinical trial information for NCT06328829 through Pure Global AI's free database. This phase not specified trial is sponsored by Copka Sonpashan and is currently Not yet recruiting. The study focuses on Alzheimer Disease. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Copka Sonpashan
Chao Phya Abhaibhubejhr Hospital
Timeline & Enrollment
N/A
Mar 01, 2024
Dec 01, 2024
Primary Outcome
Concentration of Hemoglobin,Concentration of Serum albumin,Concentration of Total serum protein,Concentration of Serum prealbumin,Body Mass Index
Summary
This is a prospective multicenter study with Alzheimer's patients with dysphagia. Patients
 enrolled are randomly divided equally into the observation group and the control group. All
 patients receive conventional care, and the observation group received Intermittent
 Oral-esophageal Tube Feeding while the control group received Nasogastric Tube Feeding for
 enteral nutrition support. Baseline information (demographics, medical history, etc.),
 nutritional status at admission and after treatment, depression, dysphagia, and quality of
 life after treatment are compared.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06328829
Non-Device Trial